Pharma News

Honeywell announced that it has signed a definitive agreement to acquire the Seelze, Germany-based laboratory research chemicals business from Sigma-Aldrich for approximately 105 million euro.

[adsense:336x280:8701650588]

The contract development and manufacturing organisation, Recipharm AB (publ) entered into an agreement whereby it will acquire a majority stake in Nitin Lifesciences Limited (“Nitin”), an Indian sterile injectables CMO, currently owned by the Sobti family.

Being sedentary for too long during the day may be a risk factor for chronic kidney disease, according to a study.

 Increasing a crucial cholesterol-binding membrane protein in nerve cells (neurons) within the brain can improve learning and memory in aged mice, a new study shows.

Pharma major Biocon's research arm Syngene International Ltd reported Rs.52 crore net profit for second quarter of fiscal 2015-16 from Rs.40 crore in the same period last year, posting 31 percent annual growth.

Pharma major Biocon on Tuesday reported Rs.306 crore net profit for second quarter of 2015-16, a whopping 200 percent growth over the same period last year due to income from the public issue of its research arm Syngene International Ltd.

The Food Safety and Standards Authority of India (FSSAI) will come out with new regulations on product approvals in a few months, a senior government official said on Tuesday.

Mice studies by researchers at University of Toronto have revealed that nicotine gives brain more codeine relief, putting smokers at a higher risk for addiction. The study is published in Neuropsychopharmacology.

Pfizer Inc's subsidiary Hospira has secured an Indian patent for an improved process for the preparation of Cilastatin. Cilastatin is a chemical which acts with anti-biotic Imipenem for the treatment of infections in various body systems. Imipenem and Cilastatin are combined in a drug to make an anti-biotic.  It is used to treat serious infections that are mild to moderate in severity, such as lower respiratory infection and heart valve infection.